STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Overview Net Sales of $76.0 Million Up 30% and Constant Currency Net Sales of $80.0 Million Up 37% from the Prior Year Quarter ICL Sales of $72.0 Million Up 33% and Constant Currency ICL Sales of $75.2 Million